Dementia Risk Declining With Each Generation, Says Promising New Study
Dementia cases are on the rise around the world. In 2021, 57 million people were living with one of the neurodegenerative diseases under the dementia umbrella, and by 2050, that number is expected to reach 153 million.
But a new study suggests the tides may be turning, with younger generations facing lower risks for the disease as they age.
The research team, led by economist Xiaoxue Dou from the University of Queensland in Australia, ran a cross-sectional observational study using health survey data from the US, Europe and England: one that's representative of cross-sections of the populations involved at a single point in time, and based on observational data.
The researchers only used variables that were available across all the survey data to estimate participants' dementia status, to compensate for any missing observations.
"Birth cohorts born more recently were less likely to develop dementia in all three regions, albeit at different rates," the authors state in a journal article. "This decreasing trend was more pronounced among women than men."
They particularly focused on people aged 71 years or older, with the data sorted into age groups spanning four years. Compared with the older groups, younger cohorts had lower age-specific dementia prevalence rates: 21.2 percent for those in the US study; 38.9 percent in the European study; and 28.3 percent in England.
"For example, in the US, among people aged 81 to 85, 25.1 percent of those born between 1890-1913 had dementia, compared to 15.5 percent of those born between 1939-1943," economist and co-author Sabrina Lenzen of the University of Queensland told Nicola Davis at The Guardian.
The team cautions their data may not accurately reflect what is happening in minority groups. But the findings suggest that, while aging populations globally will probably mean greater numbers of people living with dementia, the percentage of people affected may actually be decreasing, at least among the groups studied.
This generational decrease in dementia risk, the study's authors write, "has important implications for health care planning, long-term care policies, and workforce requirements in aging populations."
This research was published in JAMA Network Open.
Several Psychiatric Disorders Share The Same Root Cause, Study Finds
New Smart Dental Floss Can Detect Your Stress From Saliva
Gluten Intolerance vs Celiac Disease: Experts Reveal The Key Differences
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Sly Stone, 82, dies after 'prolonged battle' with COPD: Signs, symptoms and risk factors
Sly Stone, the funk icon and frontman of the group Sly and the Family Stone, has died. The 82-year-old musician's family confirmed the death of their "beloved dad" following a "prolonged battle" with COPD (chronic obstructive pulmonary disease) and undisclosed "underlying health issues." "Sly passed away peacefully, surrounded by his three children, his closest friend and his extended family,' the family's June 9 statement read. 'While we mourn his absence, we take solace in knowing that his extraordinary musical legacy will continue to resonate and inspire for generations to come.' This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle. Stone, born Sylvester Stewart, helped pioneer a new sound of funk, pop and rock in the '60s, '70s' and '80s with hits like "Dance to the Music," "Sing a Simple Song" and "Everyday People." Stone and his band were inducted into the Rock & Roll Hall of Fame in 1993 and received a Lifetime Achievement Grammy Award in 2006. "His iconic songs have left an indelible mark on the world, and his influence remains undeniable." the family's statement continued. "In a testament to his enduring creative spirit, Sly recently completed the screenplay for his life story, a project we are eager to share with the world in due course, which follows a memoir published in 2024." Stone addressed his health issues in a 2023 interview with The Guardian. 'I have trouble with my lungs, trouble with my voice, trouble with my hearing and trouble with the rest of my body, too,' he said. Stone later added that his ailments, "haven't stopped me from hearing music, but they have stopped me from making it." What is COPD is it something you should worry about when it comes to your own health? Read on to learn more about COPD. COPD is a progressive lung disease that causes airways to become swollen and blocked. It's an umbrella term used to describe various lung conditions, including chronic bronchitis and emphysema, according to COPD Canada. In chronic bronchitis, the airways in your lungs become inflamed and narrowed. This means eventually, you will develop more mucus, leading to a persistent cough and difficulty breathing. For emphysema, the disease develops over time and involves the gradual damage of tiny air sacs in your lungs called alveoli. The damage eventually causes these air sacs to rupture, reducing the surface area that lets oxygen move through the bloodstream. The most common symptoms of COPD are difficulty breathing, chronic cough (sometimes with mucus) and feeling tired, according to the World Health Organization (WHO). The Canadian Lung Association added a person with COPD might also present some of the following symptoms: Feeling short of breath Lung infections (like the flu or pneumonia) that may last longer than they would in others Wheezing Losing weight without trying These symptoms can get worse quickly and may be called flare-ups. "These usually last for a few days and often require additional medicine," WHO stated. COPD develops over time, often as a result of a combination of risk factors, according to the WHO. These may include: Smoking or being exposed to second-hand smoke Exposure to dusts, fumes or chemicals in the workplace Indoor air pollution from sources like burning fuel for heat or coal to cook Asthma in childhood Early life events, including poor growth in utero, prematurity or frequent respiratory infections A rare genetic condition called alpha-1 antitrypsin deficiency The Canadian Lung Association indicated adults over age 40 who smoke or previously smoked may be at risk of COPD. "It is important to speak to a healthcare provider if you are at risk of COPD, even if you don't have symptoms or have only mild symptoms," the organization stated. "COPD is a progressive disease, meaning it gets worse over time." COPD is severely underdiagnosed, according to the health charity. That's because people living with the disease may not show any symptoms, or they link their symptoms to factors like age, a common respiratory infection or a "smoker's cough." Moreover, some people who have stopped smoking may believe they can no longer develop COPD. Historically, COPD was associated with older men who had a history of smoking. While the number of men and women who die of COPD in Canada each year is roughly equal, recent research has indicated COPD is likely underdiagnosed in women. The Canadian Lung Association shared women might also experience more severe symptoms and have earlier disease onset. Finally, over the past two decades, there has been a rising number of COPD hospitalizations for both women in the 40 to 64 age group as well as those older than 65. That's in addition to a decreasing number of hospitalizations in men. View this post on Instagram A post shared by Lung Health Foundation (@lunghealthfoundation) In Canada, one in four people will be diagnosed with COPD. There are more than two million Canadians impacted by the disease, and a further one million likely living with the condition unknowingly. COPD is also the second-leading cause of hospitalization in Canada, behind only childbirth. Globally, the WHO has indicated COPD is the third-leading cause of death, causing more than three million deaths in 2019 alone. That year, there were more than 212 million prevalent cases of COPD reported worldwide. There is no cure for COPD. Still, there are ways to improve the condition and possibly slow its progression. Since the majority of COPD cases are related to using cigarettes, it's best to never smoke — or stop smoking now. Moreover, you should speak to your supervisor about protection if you work around occupational exposure to chemical fumes, dusts or anything other elements that may increase your risk for COPD.
Yahoo
an hour ago
- Yahoo
Common Psychiatric Medications May Increase Risk of ALS
New research shows that people who take certain psychiatric medications may be more likely to develop amyotrophic lateral sclerosis (ALS), which is the most common form of motor neurone disease (MND). This study, which was led by a team from the Karolinska Institute in Sweden, raises some important questions about the connections between psychiatric symptoms, ALS, and MND, and how they might be targeted for treatment. Anxiolytics, hypnotics and sedatives, and antidepressants are the most commonly prescribed drugs for psychiatric disorders such as anxiety, depression, and sleep problems. In terms of increased ALS risk, it worked out as 34 percent, 21 percent, and 26 percent respectively for the three drug types. The increased risk is extremely small when taken in context with the low prevalence of ALS itself. Yet understanding these links could help improve our understanding of motor neurone disease and provide insights for specialists prescribing ways to treat common psychiatric disorders. "In this case-control study, prescribed use of anxiolytics, hypnotics and sedatives, or antidepressants was associated with a higher subsequent risk of ALS," write the researchers in their published paper. "Prediagnostic use of such medications was also associated with a poor prognosis after ALS diagnosis." At the moment, there's no cure for the progressive debilitation that ALS causes, as parts of the nervous system break down – leading to paralysis and, eventually, respiratory failure. The team also identified a slight increase in rate of decline and risk of an earlier death among those diagnosed with ALS who had been exposed to one of a number of psychiatric medications. The researchers used national health data in Sweden to compare 1,057 people with ALS who had been diagnosed between 2015 and 2023 with more than 5,000 controls matched for age and sex who had no MND diagnosis. The researchers also accounted for genetic and environmental factors in their analysis, further backing up the idea that the increased risk of ALS was connected to the medication – or the reasons the medications were prescribed. The data isn't enough to show the drugs are directly causing the increase in ALS risk. It's also possible that other health-related factors are causing both the prescription of psychiatric medications, and the higher likelihood of an ALS diagnosis. "This study adds to growing evidence that individuals with psychiatric conditions may face an elevated risk of neurodegenerative diseases such as ALS," says neuroscientist Susannah Tye, from the University of Queensland in Australia, who was not involved in the study. "However, the implication that psychiatric medications themselves contribute to this risk should be interpreted with caution." Given that previous research has found people with psychiatric disorders are also more at risk of developing ALS, these results may provide some much needed detail to the overall picture of how these different conditions, and their causes and treatments, fit together. It's worth noting that ALS remains a rare condition, affecting around 9 in 100,000 people in the US. Depression and anxiety are much more common, which means millions of people take these medications to treat their mental health without ever developing ALS. Over time though, scientists are gradually understanding the different factors that affect ALS risk, which should provide clues as to how it might one day be effectively treated. The research has been published in JAMA Network Open. Dementia Risk Declining With Each Generation, Says Promising New Study Several Psychiatric Disorders Share The Same Root Cause, Study Finds New Smart Dental Floss Can Detect Your Stress From Saliva
CNBC
2 hours ago
- CNBC
See interesting case for Europe if they can get their act together: BNP Paribas AM
Carmine De Franco of BNP Paribas Asset Management believes European valuations are attractive compared to the U.S., with sector strength lying in health care and defense, instead of technology.
